Pricing Log in Create free account
Saturday 17 October 2026 Export DHR’s income statement to Excel — free account

Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.

228.97 2.53 −1.09%
Market cap
$162.7B
P/E
40.5×
Fwd P/E
29.2×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Danaher Corporation (DHR) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Danaher Corporation (DHR) trades at a EV/EBITDA of 23.7×. Over the past ten years it has ranged from 9.3× (September 2015) to 30.7× (September 2020); the current reading is higher than 75% of that period. That is in line with the Diagnostics & Research industry median of 24.3× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 24.8× (0.95%)
FY2024 25.0× 0.47%
FY2023 24.9× 32.58%
FY2022 18.8× (29.96%)
FY2021 26.8× 12.44%
FY2020 23.9× 7.58%
FY2019 22.2× 28.72%
FY2018 17.2× (4.71%)
FY2017 18.1× 22.61%
FY2016 14.8× (18.12%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 20.1× (0.15%)
Mar 2026 20.2× (18.66%)
Dec 2025 24.8× 11.61%
Sep 2025 22.2× (2.75%)
42 more quarters

Against its own ten years

Low 9.3× High 30.7×
Ten-year median 21.0×
Current reading's percentile 75

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
IQV IQVIA Holdings Inc. compare 17.1×
DHR Danaher Corporation 23.7×
TMO Thermo Fisher Scientific Inc. compare 26.3×
A Agilent Technologies, Inc. compare 26.5×
MTD Mettler-Toledo International, Inc. compare 26.6×
IDXX IDEXX Laboratories, Inc. compare 27.6×
ILMN Illumina, Inc. compare 35.0×
WAT Waters Corporation compare 50.1×
Diagnostics & Research industry median 24.3×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on DHR